7th International Conference on Accelerating Biopharmaceutical Development (AccBio 2021) | AIChE

The need to rapidly develop and commercialize therapeutics to fight COVID-19 has highlighted the importance of accelerating manufacturing development, and there are opportunities for the industry to carry...

Read more

Keynote Speakers

Invited Speakers

Conference Chairs

  • Cleo Salisbury
    Genentech
  • Gregg Nyberg
    Merck

Scientific Advisory Committee

  • Dana Anderson
    Denali Therapeutics
  • Katy Barglow
    4D Molecular Therapeutics
  • Tim Charlebois
    Pfizer
  • Charles Cooney
    Massachusetts Institute of Technology
  • Rohini Deshpande
    Amgen
  • Chetan Goudar
    Amgen
  • Aine Hanly
    Amgen
  • Brendan Hughes
    Bristol-Myers Squibb
  • Brian Kelley
    VIR Biotechnology, Inc.
  • Kelvin Lee
    University of Delaware
  • Christopher Love
    Massachusetts Institute of Technology
  • Gregory Naugle
    Merck
  • Stefanie Pluschkell
    Pfizer
  • Arup Roy
    Eli Lilly and Company
  • Jeffrey Salm
    Pfizer
  • Eugene Schaefer
    Janssen
  • Ganesh Vedantham
    Amgen
  • Hanne Bak
    Regeneron

Session Chairs

  • Ciaran Brady
    Bristol Myers Squibb
  • Sherry Gu
    WuXi Biologics
  • Jennifer Pollard
    Merck
  • Mike Vandiver
    Just - Evotec Biologics

Top Reasons to Attend

  • Benefit from lessons learned from the pandemic
  • Meet speakers from companies on the forefront of COVID-19 therapies as well as key regulators from the FDA
  • Learn about post-pandemic opportunities
  • Hear keynote presentations from thought leaders
  • Explore all aspects of bio therapeutic development from early development to launch, regulatory to supply chain, mAB to gene therapy